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OBJECTIVES The purpose of this study was to investigate the impact of the chordae tendineae force
distribution on systolic mitral leaflet geometry and mitral valve competence in vitro.
BACKGROUND Functional mitral regurgitation is caused by changes in several elements of the valve
apparatus. Interaction among these have to comply with the chordal force distribution defined
by the chordal coapting forces (FC) created by the transmitral pressure difference, which close
the leaflets and the chordal tethering forces (FT) pulling the leaflets apart.
METHODS Porcine mitral valves (n 5 5) were mounted in a left ventricular model where leading edge
chordal forces measured by dedicated miniature force transducers were controlled by changing
left ventricular pressure and papillary muscle position. Chordae geometry and occlusional
leaflet area (OLA) needed to cover the leaflet orifice for a given leaflet configuration were
determined by two-dimensional echo and reconstructed three-dimensionally. Occlusional
leaflet area was used as expression for incomplete leaflet coaptation. Regurgitant fraction (RF)
was measured with an electromagnetic flowmeter.
RESULTS Mixed procedure statistics revealed a linear correlation between the sum of the chordal net
forces, ¥[FC 2 FT]s, and OLA with regression coefficient (minimum 2 maximum) beta 5
2115 to 265 [mm2/N]; p , 0.001 and RF (beta 5 20.06 to 20.01 [%/N]; p , 0.001).
Increasing FT by papillary muscle malalignment restricted leaflet mobility, resulting in a
tented leaflet configuration due to an apical and posterior shift of the coaptation line. Anterior
leaflet coapting forces increased due to mitral leaflet remodeling, which generated a
nonuniform regurgitant orifice area.
CONCLUSIONS Altered chordal force distribution caused functional mitral regurgitation based on tented
leaflet configuration as observed clinically. (J Am Coll Cardiol 1999;33:843–53) © 1999 by
the American College of Cardiology
Significant mitral valve regurgitation (MR) without struc-
tural tissue defect is observed in 11% of patients undergoing
coronary angiography due to coronary artery disease (1).
Since MR has an impact on the long-term prognosis after
myocardial revascularization (2), recognition of its precise
etiology may be helpful in identifying rational corrective
procedures that also improve left ventricular function.
Typically, these patients have normal leaflets that are
displaced apically, resulting in incomplete mitral leaflet
coaptation (3). Despite extensive characterization of the
phenomenon, the precise mechanism remains unclear. Sev-
eral points of view have been adopted, each providing a
seemingly rational explanation of functional MR. With the
exception of intrinsic papillary muscle dysfunction (4), the
majority have implicated a component of left ventricular
remodeling as the primary determinant of MR (3,5–11).
However, global left ventricular dysfunction is often accom-
panied by multiple alterations of the mitral valve apparatus,
any of which can lead to MR (11). Nevertheless, interaction
among the mitral valve components has to comply with the
concept of the chordal force distribution defined by the
chordal coapting forces created by the transmitral pressure
difference, which close the mitral leaflets and the chordal
tethering forces tending to pull the leaflets apart (12).
In the present in vitro study, we tested the hypothesis that
functional MR is directly related to an altered balance
between the chordal coapting and chordal tethering forces
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in ventricular systole. Therefore, the aim of the study was to
investigate the impact of the chordal force distribution on
systolic mitral leaflet configuration and severity of MR.
METHODS
In Vitro Model. The experiments were conducted in a left
heart simulator, comprising a computer-controlled,
pressure-driven compressible bladder type pulsatile pump
system (13). Hemodynamic conditions could be simulated
at heart rates from 40 to 160 min21, and cardiac output up
to 10 liter/min with physiologic pressure and flow wave
forms. A 0.9% saline solution was used as blood analog
fluid.
The measurements were conducted in a rigid left ventric-
ular model with dimensions of the human left ventricle at
the onset of systole (Fig. 1). The model allowed indepen-
dent adjustment of the papillary muscle positions over a
clinically relevant range (Fig. 2).
A transparent millimetric foil placed on the model
allowed readings of three-dimensional coordinates, where x
referred to the horizontal plane, y to the sagittal plane and
z to the axial plane. The centerpoint of the inner rigid
annular ring was defined as origo (0,0,0). In this system the
mitral valve structures could be characterized three-
dimensionally.
VALVES. Porcine mitral valves with intact chordae tendineae
and papillary muscles with an intertrigonal distance of
25 mm were tested in the model. The valves were slightly
fixated in 1% glutaraldehyde solution to prolong the tissue
integrity of the valve. Each valve had a total leaflet surface
area that was nearly twice that of the annular ring area,
which is similar to the ratio of normal human mitral valves
(14). The number and distribution of the chordae tendineae
in the porcine mitral valve are similar to human mitral valves
(15). The native mitral annulus was mounted on an inner
ellipsoid ring that was attached to a rigid round outer ring
by a waterproof Dacron cloth stretched tightly between the
two rings. The anatomic shape and size of the inner annulus
were determined by mitral valve sizers used by surgeons for
sizing of mitral annuloplasty rings (Medtronic Inc.). The
outer ring was mounted on the atrial section of the model,
so the anterior leaflet was positioned anteriorly between the
mitral orifice and the left ventricular outflow tract.
The papillary muscles were wrapped in a Dacron cuff for
support and then sutured to sewing disks on the ends of
sigmoidal mounting rods, shown in Figure 1. Although the
posteromedial and the anterolateral papillary muscles have
been designed anatomically, they both lie in the posterior
half of the left ventricle with a line joining the tips running
parallel to the coaptation line of the mitral leaflets (3). In
our model the medial scallop of the posterior leaflet was
positioned posteriorly opposite to the anterior leaflet in the
sagittal plane. Therefore, to simulate the papillary muscle
displacement that can occur in ischemic heart disease or
Abbreviations and Acronyms
APL 5 apical posterolateral
APM 5 anterolateral papillary muscle
DAL, DPL 5 distance from the anterior/posterior
leaflet tip to the annular plane
FC, FT 5 chordal coapting and tethering force
component. Subscripts AA, AP, PA, PP
refer to chordae location (chordae from
APM to the anterior leaflet, from APM
to the posterior leaflet, from PPM to
the anterior leaflet and from PPM to
the posterior leaflet). Subscripts APM
and PPM refer to the chordal forces
emanating from APM and PPM.
Subscripts AL and PL refer to the
chordal forces supplying the anterior
and posterior leaflet. Subscript S refers
to the sum of the chordal force
components
LAL, LPL 5 horizontally projected anterior and
posterior leaflet length
LAPM, LPPM,
LPM 5 papillary muscle lengths (distance from
APM/PPM tip to the annular plane
through the midpoint of the
corresponding half mitral systolic
coaptation point). LPM is the mean of
LAPM and LPPM
LVP 2 LAP 5 transmitral pressure difference
MR 5 mitral valve regurgitation
OLA 5 occlusional leaflet area of the mitral
valve. Subscript ACOM/PCOM refers
to the anterolateral/posteromedial
commissural half portion
PPM 5 posteromedial papillary muscle
RF 5 mitral regurgitant fraction
2D 5 two-dimensional
aAL, aPL 5 coaptation angle of the
anterior/posterior leaflet
wAL, wPL 5 anterior/posterior leaflet excursion angle
Figure 1. Photograph of the left ventricular model showing the
mitral valve mounting mechanism consisting of an annulus ring
and two papillary muscle mounting rods. Chordal force transduc-
ers were attached to the primary (major fixing) chordae.
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dilated cardiomyopathy (8), the papillary muscles were
retracted in apical (A), posterolateral direction (PL) and
apical posterolateral (APL) directions (Fig. 2).
MEASUREMENTS
Chordae tendineae forces. Specially self-designed chordal
force transducers were directly attached to the chordae
tendineae of the mitral valve. Each transducer was con-
structed of a C-shaped copper ring, 6 mm in diameter and
0.8 mm thick (Fig. 2). Two miniature strain gauges (model
EA-06-031DE-350, Measurements Group, Raleigh, North
Carolina) were glued to the inner and outer surface of the
ring, coated and coupled in a Wheatstone half-bridge to a
strain gauge indicator (model 1526, Bru¨el & Kjaer, Copen-
hagen, Denmark). Before use in the model, the transducers
were individually calibrated and tested for sensitivity, hys-
teresis and linearity to force units in a range of 0 to 5 N and
for electrical stability in a 0.9% saline solution. In each end
of the C-template a thin slit and two small holes were
incorporated to permit fixation of a chorda tendinea with a
Prolene 6-0 suture. After fixation, the chordal fiber was cut
between the two ends of the transducer.
In each valve, four chordal force transducers were fixated
to the marginal branch of the major fixing primary chordae
tendineae (16) (Fig. 2).
The force transducers measured the resulting force on
each chorda tendinea representing the sum of the tethering
force component (FT) directed toward the papillary muscles,
and the coapting force component (FC) directed toward the
leaflets (Fig. 3). The chordal tethering and coapting force
components were both projected along the chorda; each of
them increased the chordal tension. Since the papillary
muscles were fixated to static mounting rods, the chordal
tethering force reflected the force measurement during left
Figure 2. Schematic showing the distribution of the chordal force
transducers and the papillary muscle adjustments in normal (N),
apical (A), posterolateral (PL) and apical posterolateral (APL)
directions. Eight papillary muscle settings were tested. Scaled
photograph of the transducer: 1 unit 5 1 mm. CTAA 5 chorda
from the anterolateral papillary muscle (APM) to anterior leaflet;
CTAP 5 chorda from APM to posterior leaflet; CTPA 5 chorda
from the posteromedial papillary muscle (PPM) to anterior leaflet;
CTPP 5 chorda from PPM to posterior leaflet; AL 5 anterior
leaflet.
Figure 3. (A) Free body diagram of the mitral valve complex. In an
equilibrium condition of the closed mitral valve complex in systole,
mitral leaflet force balance (below the dashed line) requires that
the transmitral pressure forces (Fp,i) are counteracted by the
chordal tethering force, FT (equal to 2FC) and the annular
tethering force, FA. Chordal force balance (above the dashed line)
requires that the coapting force component FC is counteracted by
an equal and oppositely directed tethering force from the papillary
muscle attachment, FT. Transmitral pressure forces and FA are
only presented for schematic and conceptual purposes and were not
assessed in the study. (B) The chordal force measure of each
chorda tendinea consisted of the chordal tethering force compo-
nent (FT) and the chordal coapting force component (FC). The
difference of the force components, (FC 2 FT), defined the
resulting (valvular directed) force of the chorda tendinea acting on
the leaflets at the point of insertion.
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ventricular diastole, when there was no pressure difference
between the left ventricle and the left atrium. The chordal
tethering force was assumed to be zero when the papillary
muscles were in the normal position, and thus FT for a given
papillary muscle setting was calculated by subtracting the
observed FT with the papillary muscles in normal position
from the FT when the papillary muscles were displaced. The
chordal coapting force was the increase in the chordal force
measurement when the left ventricular pressure was applied
to close the valve. The difference between the coapting and
tethering force component (FC 2 FT) of each chorda
defined the resultant force that determined leaflet position
at the point of insertion.
The spatial orientation of the chordae connecting the
papillary muscle tip and the midpoint of the corresponding
half mitral systolic coaptation line were determined by
two-dimensional (2D) echocardiographic (see below).
Hence, the measured chordal forces could be resolved into x
(horizontal), y (sagittal) and z (axial) components: FT(x),
FT(y), FT(z), FC(x), FC(y), FC(z).
Theoretically, the total chordal force balance is given by
the vector summation of the tethering and coapting force
vectors of all the chordae supporting the anterior and
posterior leaflet (12). Using only four chordal force trans-
ducers, we could not actually measure the total chordal force
balance. However, we anticipate that relative changes of the
chordal force distribution were reflected by our measure-
ments and could be used to interpret the relation between
leaflet configuration and the overall chordal force distribu-
tion.
Hemodynamics. The transmitral pressure difference
(LVP 2 LAP) was measured by a differential pressure
transducer (model DP15 TL, Validyne Inc., Northridge,
CA) coupled to an amplifier/signal conditioner (model
CD12 A-1-A, Validyne Inc., Northridge, California).
Transmitral flow rates were measured in the left atrium
4 cm upstream of the valve by an electromagnetic cannular
flow probe with a 25.4-mm internal bore (model EP680,
Carolina Medical Instruments Inc., King, North Carolina),
coupled to an analog flowmeter (model FM 501, Carolina
Medical Instruments Inc., King, North Carolina).
Mitral valve imaging. Two-dimensional echocardio-
graphic recordings were made with a phased array ultra-
sound sector scanner (Sonolayer SSA-270A, Toshiba Inc.)
using a 3.75-MHz probe (PSF-37DT). Machine settings
were adjusted to provide optimal imaging with the highest
possible frame rate at a penetration depth of 12 cm.
The ultrasound transducer was positioned at the apex of
the left ventricular model and rotated counterclockwise
from the horizontal plane (0°) in 45° steps. Thus, 2D
echocardiographic recordings from four different scanning
planes were obtained: 1) 0°, 2) 45°, 3) 90° (apical long-axis
view) and 4) 135° (apical four-chamber view). In addition,
2D echocardiographic recordings were obtained from
parasternal long-axis and short-axis views. All echocardio-
graphic data were recorded on videotape, and representative
heart cycles were later transferred synchronized with the
transmitral flow curve to a computer for off-line analysis in
a commercially available software program (EchoPAC,
VingMed, Norway).
Data Analysis
Transmitral pressure difference, mitral flow, chordal force
and pump trigger signals were stored on a tape recorder
(TEAC RD 180T PCM, Teac Corp., Japan) for off-line
analysis on a computer after analog-to-digital conversion
with a sample frequency of 300 Hz. By a dedicated software
program (designed in LabVIEW 4.01), one mean pump
cycle from each channel was obtained by ensemble averag-
ing 10 pump cycles.
Chordae tendineae forces. Peak chordal FC and FT were
assessed from the chordal force signals. Coapting force
component and FT were resolved into x,y,z vectors knowing
the orientation of the chordae (see below). The magnitude
of the total chordal net force, ¥[FC 2 FT]S, the chordal net
force of anterior leaflet, ¥[FC 2 FT]AL, and posterior
leaflet, ¥[FC 2 FT]PL, and from anterolateral papillary
muscle, ¥[FC 2 FT]APM, and posteromedial papillary
muscle, ¥[FC 2 FT]PPM, were determined as the sum of the
square root square of ¥[FC 2 FT](x), ¥[FC 2 FT](y) and
¥[FC 2 FT](z) of the respective chordae.
Hemodynamics. Early systolic peak 1 (LV 2 LA) dP/dt
were computed from the LVP 2 LAP pressure recordings.
From the transmitral flow data the following parameters
were calculated: forward flow volume, regurgitant flow
volume, stroke volume and mitral regurgitant fraction (RF).
The closing volume represented the fluid displaced by the
valve during closure. The precoaptation regurgitant volume
was defined as the difference between the measured closing
volume in the test condition and the closing volume of the
same valve for the normal papillary muscle position and
same physiologic condition.
Mitral valve imaging. Echocardiographic data were used
to assess mitral leaflet mobility and systolic leaflet configu-
ration.
LEAFLET COAPTATION. In each apical view, the following
parameters were measured (Fig. 4): the perpendicular pro-
jected distance from the annular plane to the anterior and
posterior leaflet tip (DAL and DPL); the projected length of
the leaflets (LAL and LPL); the leaflet coaptation angle (aAL
and aPL), and the leaflet excursion angle, which was defined
as the angle through which each leaflet travelled (wAL and
wPL; not shown). Except for leaflet excursion angle, only
one representative early midsystolic frame per view was
analyzed.
OCCLUSIONAL LEAFLET AREA. The occlusional leaflet area
(OLA) was defined as the leaflet surface area required to
cover the mitral orifice for a given leaflet geometry orienta-
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tion and was used as an integrated measure for mitral leaflet
tenting. The relative increase of OLA for a certain papillary
muscle position in comparison with the normal condition
thus reflected the severity of incomplete mitral leaflet
coaptation, and may also be a reliable measure to reflect the
presence of a regurgitant orifice area (see below). Occlu-
sional leaflet area was calculated as follows. The leaflet
contour of the tented leaflet configuration in a given apical
scanning plane may be approximately described by four
heights (h1..h4) and four radii (r1..r4) (Fig. 4). Assuming
that this leaflet contour is swept through 45° of rotation
about the center point of the annulus, OLA can be
calculated as the sum of fractions of a cone produced from
the four scanning planes, according to (modified from
Boltwood et al. [9]):
OLA 5 3O1
4
p
8
@~r1 1 r2!~h12 1 ~r1 2 r2!2!1/ 2 1 r2 ~r22 1 h22!1/ 2
1 r3~r32 1 h32!1/ 2 1 ~r1 1 ~r1 2 r4!~h42 1 r42!1/ 2!
1 ~~r1 2 r4! 1 r3!~~h4 2 ~h1 1 h2 1 h3!!2
1 ~r1 2 ~r3 1 r4!!2!1/ 2#
,
[1]
in which r4 and h4 can be solved trigonometrically. The
measure of OLA does not account for leaflet infolding or
compression of leaflet tissue at the line of coaptation. Based
on the equation for OLA, the occlusional leaflet area of the
anterolateral and posteromedial commissural half portion of
the mitral orifice (OLAACOM and OLAPCOM) could easily
be calculated. Line 3–4 in the equation refers to the leaflet
edge separation, which by summation gives the effective
regurgitant orifice area, and was canceled out in complete
leaflet coaptation. However, the regurgitant orifice area
itself may be difficult to assess precisely by 2D echo due to
limitations of the spatial resolution.
CHORDAE AND PAPILLARY MUSCLE SPATIAL ORIENTATION.
Assuming that the chordae tendineae with origin at the
papillary muscle tip were inserting at the midpoint of the
corresponding half mitral systolic coaptation line in early
systole, the spatial orientation of the chordae connecting
these coordinates could be calculated. The x,y,z coordinates
of the papillary muscle tips were directly read in the spatial
coordinate system of the left ventricular model. The mitral
leaflet geometry assessed by 2D echo could be superimposed
on this spatial coordinate system, having a well defined
annular hinge and scanning planes.
From the parasternal short-axis view, the x,y coordinates
of the medial and lateral midpoint of the half mitral systolic
coaptation line could be identified (asterisks in Fig. 5). The
transducer was then moved along the x axis to center the
medial and lateral midpoint of the half mitral systolic
coaptation line in the scanning planes. In these positions the
transducer was rotated 90° into parasternal long-axis view,
in which the z component of the midpoint of the half mitral
systolic coaptation line could be measured as the distance
from the leaflet tips to the annular plane.
Figure 4. Diagram of a midsystolic tented mitral leaflet geometry (left top) with a typical leaflet contour imaged by two-dimensional echo
from the apical view (below). Left ventricular side in z direction. The occlusional leaflet area, OLA, was calculated as the sum of fractions
of a cone produced from four apical scanning planes rotated around an axis through the midpoint of the annulus (right top; one fraction
of a cone is marked). Notice leaflet edge separation due to leaflet asynergy creating a regurgitant orifice. Variables to describe leaflet
configuration are illustrated (r and h). The intersection of the anterior leaflet extension on the posterior leaflet gives the horizontal length
r4 and perpendicular distance h4 of the posterior leaflet involved in mitral orifice occlusion. aAL and aPL 5 systolic leaflet coaptation angle
of the anterior and posterior leaflet; DAL, DPL 5 perpendicular distance from anterior and posterior leaflet tip to the annular plane; LAL,
LPL 5 horizontally projected lengths of the anterior and posterior leaflet.
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The central papillary muscle lines (double arrows in Fig.
5) were defined between the papillary muscle tips through
the corresponding midpoints of the half mitral systolic
coaptation line to the annular plane. The length of the
papillary muscle lines (LAPM and LPPM) and the mean of
LAPM and LPPM (LPM) designated the papillary muscle
malalignment with respect to the mitral annulus.
Study Conditions
Five valves were included in the study. Alterations of the
chordal force distribution were accomplished by combina-
tions of 1) eight different papillary muscle settings (Fig. 2),
2) two peak LVP 2 LAP settings (90 and 150 mm Hg) and
3) two heart rate settings (70 and 120 min21). Cardiac
output was kept constant at 5 liters/min or at maximum
obtainable flow rate during moderate to severe MR. Two
different levels of peak 1 (LV 2 LA) dP/dt were accom-
plished by the two heart rate settings.
Statistics
The data were analyzed using mixed models (17), which are
unbalanced analysis of variance models, allowing more than
one source of variation (random effects) and both nominal
(valve, papillary muscle settings, high/low LVP 2 LAP and
high/low heart rate) and continuous (e.g., LPM and ¥[FC 2
FT]S) independent variables (fixed effects). The Proc Mixed
procedure in SAS was used for the analysis. Tests to
determine whether the fixed effects were statistically signif-
icant were performed for each valve and for all valves at
once. Significance level was p 5 0.05.
Three different models were applied:
Model 1MP. The dependent variable Y (e.g., RF) was
analyzed in relation to variation in papillary muscle settings,
high/low LVP 2 LAP and high/low heart rate:
Y 5 aPM 1 gLVP 2 LAP IHigh pressure 1 gHR IHigh heart rate 1 error term,
where aPM was the level for the eight papillary muscle
settings, gLVP 2 LAP was the difference between high/low
heart rate and IA was the indicator function equal to 1 if A
was true (high pressure/heart rate) and 0 if A was false (low
pressure/heart rate).
Model 2MP. The dependent variable Y (e.g., RF) was
analyzed in relation to variation in a continuous variable X
(e.g., ¥[FC 2 FT]S), high/low LVP 2 LAP and high/low
heart rate:
Y 5 a 1 bzX 1 gLVP2LAP IHigh pressure 1 gHR IHigh heart rate
1 error term,
where b was the regression coefficient of X, a the intercept
and g and I as stated above.
The range of the continuous variable X (RX) was defined
as the difference between the maximum and minimum value
of X in all experiments in the same valve. Hence, the
magnitude of bzRX, gLVP2LAP and gHR indicated the
contribution of X, LVP 2 LAP and heart rate settings to
the dependent variable, Y. Due to the variation between
valves, the magnitudes of b and bzRX are stated for each
valve in tables or as minimum to maximum value of five
valves in the text.
Model 3MP. The dependent variable Y (e.g., RF) was
analyzed in relation to variation in two continuous variables
X1 and X2 (e.g., LPM and ¥[FC 2 FT]S), high/low LVP 2
Figure 5. Schematic representation of the three-dimensional re-
construction of the mitral leaflet geometry, using one short-axis
view of the annulus plane (top) and two parasternal long-axis views
at the midpoint of the half mitral coaptation line (bottom). The
primary chordae connected the tip of the papillary muscles and the
corresponding midpoint of the half mitral coaptation line (aster-
isks). The central papillary muscle lines (LAPM and LPPM) are
illustrated as double arrows from the papillary muscle tips through
the chordae attachment (asterisks) to the annular plane. APM 5
anterolateral papillary muscle; PPM 5 posteromedial papillary
muscle.
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LAP and high/low heart rate, that is, the regression term
bzX in model 2 was changed to b1zX1 1 b2zX2.
The error terms in the models contained a component for
each of the sources of variation: one common for the four
measurements on the same valve and same papillary muscle
setting (model 2 and 3), one common for two measurements
(high/low LVP 2 LAP) in the same valve, same papillary
muscle setting and same heart rate and finally a residual
term.
RESULTS
With the papillary muscles mounted in normal position, 2D
echocardiograms showed complete mitral leaflet coaptation
with no detectable regurgitation in any of the valves at the
four test conditions. The clinically observed tented leaflet
geometry was successfully reproduced by papillary muscle
displacement.
Determinants of leaflet configuration. Table 1 shows
selected leaflet variables in relation to papillary muscle
settings. Occlusional leaflet area was significantly related to
papillary muscle settings (p , 0.001) and LVP 2 LAP (p ,
0.001) (model 1MP). A positive correlation was found
between LPM and OLA (OLA: beta 5 22 to 35 [mm
2/
mm], bzRLPM 5 261 to 552 mm
2; p , 0.001). Increasing
LVP 2 LAP reduced OLA in all valves (gLVP 2 LAP 5 245
to 210 [mm2]; p , 0.001). Occlusional leaflet area was
variably related to peak 1 (LV 2 LA) dP/dt (OLA: gHR 5
237 to 148 [mm2]).
Table 2 shows the chordal force distribution in relation to
papillary muscle settings. ¥[FC 2 FT]S was a central factor
governing variations of OLA (Table 3). A strong correlation
was found between ¥[FC 2 FT]S and OLA (Fig. 6). Table
3 shows that the impact of LVP 2 LAP on OLA
(gLVP 2 LAP 5 214 to 147 [mm
2]; p 5 NS in four valves)
was compensated by the variations of ¥[FC 2 FT]S. Using
¥[FC 2 FT]S and LPM in a covariate analysis for OLA, the
significant impact of LPM on OLA was entirely neutralized
by variations of ¥[FC 2 FT]S (LPM: p 5 0.46 vs. ¥[FC 2
FT]S: p , 0.001 [model 3
MP]).
Increasing chordal tethering forces by displacement of the
papillary muscle restricted leaflet mobility tending to pull
the corresponding leaflets apart. A positive correlation was
found between ¥[FC 2 FT]AL and anterior leaflet excursion
angle wAL (beta 5 2.0 to 8.3 [°/N]; p , 0.001 [model 2
MP])
and between ¥[FC 2 FT]PL and posterior leaflet excursion
angle wPL (beta 5 4.7 to 12.0 [°/N]; p , 0.001 [model
2MP]). Increasing the z component of the tethering forces
by apical papillary muscle displacement significantly in-
creased DAL and DPL (DAL vs. ¥[FC 2 FT]AL[z]: beta 5
23.3 to 21.2 [mm/N], p 5 0.01; DPL vs. ¥[FC 2
FT]PL[z]: beta 5 23.3 to 21.3 [mm/N]; p , 0.001 [model
2MP]). Similarly, increasing the y component of the tether-
ing forces by posterolateral papillary muscle displacement
significantly increased LAL and decreased LPL (LAL vs.
¥[FC 2 FT]AL[y]: p , 0.01; LPL vs. ¥[FC 2 FT]PL[y]: p ,
0.01 [model 2MP]).
Hence, apical papillary muscle displacement resulted in
an apical shift of the leaflet coaptation line, whereas pos-
terolateral displacement of the papillary muscles caused a
remodeling of the mitral leaflet surface area in which the
anterior leaflet covered a larger part of the mitral orifice,
resulting in a posterior shift of the leaflet coaptation line
(Fig. 7). Therefore, by posterolateral displacement of the
papillary muscles the chordal coapting force component of
the anterior leaflet increased due to a larger leaflet surface
area disposed, which counterbalanced increasing tethering
forces and thereby prevented excessive apical migration of
the anterior leaflet. Leaflet infolding along the coaptation
line reduced the effective posterior leaflet surface area
disposed, thereby decreasing the chordal coapting force
component of the posterior leaflet. Therefore, posterior
leaflet mobility was restricted partly due to increasing
chordal tethering forces partly due to decreasing chordal
coapting forces of the posterior leaflet.
Separate changes of the posterior papillary muscle (nor-
Table 1. Selected Mitral Leaflet Variables in Relation to Papillary Muscle Settings
APM:PPM
Settings
Mitral Leaflet Variables
DAL
(mm)
DPL
(mm)
wAL
(°)
wPL
(°)
OLA
(mm2)
OLAACOM
(mm2)
OLAPCOM
(mm2) RF
N:N 7.2 6 0.5 10.0 6 0.5 70 6 1.2 39 6 1.8 600 6 28 304 6 16 296 6 13 —
A:A 9.4 6 0.7 11.8 6 0.5 67 6 1.3 31 6 1.6 685 6 26 345 6 15 340 6 11 0.08 6 0.01
N:PL 8.0 6 0.5 12.0 6 0.5 69 6 1.4 26 6 2.1 706 6 27 354 6 16 351 6 13 0.11 6 0.01
N:APL 8.4 6 0.5 13.9 6 0.5 67 6 1.7 19 6 2.1 784 6 30 387 6 13 397 6 17 0.13 6 0.02
PL:PL 7.2 6 0.4 14.7 6 0.5 69 6 1.3 13 6 1.6 843 6 31 427 6 17 416 6 15 0.15 6 0.02
PL:APL 8.4 6 0.5 15.5 6 0.5 67 6 1.3 12 6 1.9 886 6 33 451 6 18 436 6 16 0.16 6 0.02
APL:PL 7.8 6 0.5 15.7 6 0.6 68 6 1.2 7 6 1.0 939 6 37 489 6 21 450 6 19 0.17 6 0.02
APL:APL 9.7 6 0.6 15.9 6 0.5 64 6 1.5 10 6 2.1 948 6 35 489 6 21 459 6 15 0.26 6 0.04
Data are expressed as means 6 SEM of four physiologic conditions for each papillary muscle setting in all valves.
A 5 apical; APL 5 apical posterolateral; APM 5 anterolateral papillary muscle; DAL, DPL 5 perpendicular distance from anterior and posterior leaflet tip to annular plane
(apical long-axis view); N 5 normal; OLA, OLAACOM, OLAPCOM 5 the total occlusional leaflet area and the anterior and posterior commissural half portion of OLA;
PL 5 posterolateral; PPM 5 posteromedial papillary muscle; RF 5 regurgitant fraction; wAL, wPL 5 anterior and posterior leaflet excursion angle (apical long-axis view).
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mal:PL, normal:APL papillary muscle settings) increased
[FT]PA and [FT]PP and also caused a reduction of the
chordal coapting forces of the posterior leaflet on both sides
of the commissures ([FC]AP and [FC]PP) (Table 2). Pos-
teromedial papillary muscle displacement thus affected the
corresponding half portion of occlusional leaflet area,
OLAPCOM, but tended also to increase OLAACOM, even
though the anterolateral papillary muscle position was
unchanged (Table 1).
Determinants of regurgitant fraction. Mitral regurgitant
fraction significantly increased with papillary muscle dis-
placement (p , 0.001, model 1MP). Apical papillary muscle
displacement was sufficient to create MR; however, postero-
lateral and apical posterolateral displacement was necessary
to create more important and clinically significant MR
(Table 1). Increasing LVP 2 LAP tended to increase RF
(gLVP 2 LAP 5 20.03 to 13.9 [%]; p , 0.001), even though
that LVP 2 LAP caused a reduction of OLA. In four of
five valves, RF was virtually unaffected by changes of heart
rate (gHR 5 0.2 to 2.4 [%], p 5 NS). Only in one valve was
RF significantly higher at heart rate of 120 min21 than of 70
min21 (gHR 5 5.1 [%], p , 0.001). However, RF may be
affected by the relative systolic and diastolic duration, which
was not fully comparable in the two heart rate settings. In
contrast, the early systolic precoaptation regurgitant volume
was actually significantly reduced with increasing heart rate
(gHR 5 20.06 to 20.008 [liter]; p , 0.001, Model 1
MP).
Using regression analysis (model 2MP), RF was closelyTa
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Table 3. Impact of Chordal Force Distribution on Occlusional
Leaflet Area and Mitral Regurgitant Fraction
Valve
OLA: Independent Variables ¥[FC 2 FT]S (N)
b
(mm2/N)
bzR¥[FC2FT]S
(mm2)
gLVP2LAP
(mm2)
gHR
(mm2)
SD
(mm2)
1 2115* 601 20 11 49
2 282* 312 21 48† 43
3 276* 317 214 47† 34
4 279* 408 0 219 35
5 264* 445 47* 243† 28
Valve
RF: Independent Variables ¥[FC 2 FT]S (N)
b
(%/N)
bzR¥[FC2FT]S
(%)
gLVP2LAP
(%)
gHR
(%)
SD
(%)
1 24.1* 21.6 3.2* 4.4† 2.9
2 26.7* 25.4 3.6* 0.4 3.5
3 21.1* 4.6 0.9† 2.1† 1.1
4 22.5* 12.8 1.4† 1.4† 1.7
5 26.4* 44.3 9.6* 1.7† 1.8
*p , 0.001. †p , 0.05. Occlusional leaflet area (OLA) and regurgitant fraction (RF)
(dependent variables) versus total chordal net forces of the primary chordae (¥[FC 2
FT]S) (independent variable) using mixed procedure, model 2
MP. The magnitude of
the regression terms (e.g., bzR¥[FC2FT]S) in comparison to gLVP 2 LAP and gHR
shows the relative contribution of each factor on the dependent variables. b 5
regression coefficient; gLVP 2 LAP and gHR 5 difference of the dependent variable
between transmitral pressure difference and heart rate settings; R¥[FC2FT]S 5 range of
¥[FC 2 FT]S (maximum 2 minimum value of all experiments in one valve); SD 5
standard deviation (square root of the sum of three variance components).
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related to variations of ¥[FC 2 FT]S (Table 3 and Fig. 6) as
well as OLA (beta 5 0.014 to 0.091 [%/mm2]; p , 0.001).
DISCUSSION
By application of the premise of the chordal force balance,
incomplete mitral leaflet coaptation can be a result of: 1)
abnormally increased tension caused by displacement of
the annular (9) and papillary muscle attachment (3– 8)
and 2) decreased global left ventricular systolic function,
decreasing the coapting forces to close the mitral leaflets
(5,7,18).
Our study emphasizes that redistribution of the chordal
force balance leads to incomplete mitral leaflet coaptation.
Papillary muscle malalignment increased the chordal
tethering forces and induced functional MR based on the
tented leaflet configuration as observed clinically (3).
Increasing chordal tethering forces restricted leaflet mo-
bility, impeded mitral valve coaptation and increased regur-
gitation. In addition, redirection of the chordal force com-
ponents by a posterolateral shift of the papillary muscles
caused a remodeling of the mitral leaflet surface area. This
process can be interpreted as follows. Increased tethering
forces in posterior direction restricted posterior leaflet ex-
cursion angle. Leaflet separation was partly compensated by
the anterior leaflet covering a larger part of the mitral valve
orifice. Therefore, the mitral leaflet coaptation line moved
in an apical and posterior direction in an asymmetrical
coaptation pattern, which has also been reported clinically
(10). As a consequence, the coapting forces of the anterior
leaflet increased due to exposure of a larger leaflet surface
area. Thereby, excessive apical migration of the anterior
leaflet was prevented. Conversely, a reduction of the poste-
rior leaflet surface area due to leaflet infolding caused less
coapting force to counterbalance increasing tethering forces,
resulting in further leaflet malalignment (compare Fig. 7).
The anatomical substrate for anterior leaflet expansion may
be unfolding of the leaflet tissue at the coaptation zone
(rough zone) and stretching due to horizontal stress.
Figure 6. A linear correlation was demonstrated between the occlusional leaflet area (OLA) and regurgitant fraction (RF) (dependent
variables) and the total chordal netforces, ¥[FC 2 FT]S (independent variable). Data represent one valve at all test conditions. Trends are
representative of all valves (compare with Table 3). Solid circles 5 HR: 70; LVP 2 LAP: 90; solid squares 5 HR: 120; LVP 2 LAP:
90; open circles: HR: 70; LVP 2 LAP: 150; open squares 5 HR: 120; LVP 2 LAP: 150. HR 5 heart rate; LVP 2 LAP 5 transmitral
pressure difference.
Figure 7. Diagram showing mitral leaflet remodeling (thin arrows) caused by redistribution of the chordal tethering (thick black arrows)
and coapting forces (dotted arrows) during apical (A) and posterolateral (PL) papillary muscle (PM) displacement. Apical displacement
of the papillary muscles resulted in an apical shift of the leaflet coaptation line. Posterolateral displacement of the papillary muscles caused
a posterior shift of the leaflet coaptation line. Therefore, the chordal coapting force component of the anterior leaflet increased, generating
a nonuniform regurgitant orifice area. N 5 normal.
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Lateralization of the chordal tethering forces might have
exacerbated the degree of incomplete mitral leaflet coapta-
tion by diverting the central parts of the leaflets away from
closure (8).
Recent clinical studies of functional MR have shown
early and late systolic peaks in mitral regurgitant flow and
regurgitant orifice area, which decreases in midsystole co-
inciding with maximum transmitral pressure difference (19).
A possible explanation for this phenomenon includes in-
creased left ventricular pressure, which closes the leaflets
more effectively. This mechanism was partly supported by
our data, which demonstrated that increasing chordal co-
apting forces by changing the left ventricular pressure
reduced OLA. However, any favorable reduction of the
regurgitant orifice area for a given subvalvular geometry was
counteracted by increasing regurgitant flow velocities caus-
ing the observed increase of regurgitant volume to driving
pressure.
Increasing peak 1 (LV 2 LA) dP/dt in early systole was
associated with a reduction of the precoaptation regurgitant
volume, indicating accelerated mitral leaflet coaptation and
a relative delay of fluid momentum. However, increasing
peak 1 (LV 2 LA) dP/dt did not cause more effective
closure of the mitral leaflets (OLA insensitive to peak 1
[LV 2 LA] dP/dt). Therefore, we do not consider a slow
rate of rise of pressure, as speculated by Kaul et al. (5), to be
a primary determinant of incomplete mitral leaflet coapta-
tion and functional MR.
Using three-dimensional echocardiography to explore
geometric determinants of functional MR in a canine model
of global left ventricular dysfunction, Otsuji et al. (8)
showed that MR occurred in relation to increased papillary
muscle-to-annulus tethering length after papillary muscle
displacement in lateral and posterior direction rather than in
apical direction along the left ventricular long axis. In
agreement with our findings, it was suggested that a lateral
and posterior shift of the papillary muscles redirects papil-
lary muscle tension away from the axial direction, diverting
the leaflets away from closure. Our in vitro study elucidated
this issue further by demonstrating decreased coapting
forces of the posterior leaflet due to leaflet remodeling that
enhanced leaflet malalignment.
Recent studies in our own laboratory have shown that
annular dilation was a necessary condition to generate more
significant levels of MR (13). However, annular dilation was
not sufficient to develop the tented leaflet geometry without
papillary muscle displacement. Therefore, in the present
study we kept mitral annular dimension constant to dem-
onstrate that altered chordal force distribution accomplished
by papillary muscle displacement reproduces tented mitral
leaflet configuration and functional MR as observed clini-
cally.
Functional MR appears in an orchestra of geometric and
hemodynamic variables that accompany acute and chronic
left ventricular dysfunction. The chordal force distribution
is the key factor, which mediates the relative contribution
and interaction of these variables, and thereby determines
systolic mitral leaflet configuration.
Model considerations. Previous in vivo studies of these
mechanistic factors of functional MR have provided data of
limited value for two reasons. First, proposed causes of MR
could not be deliberately varied to show that they induced
regurgitation in an initially competent valve (11). Second,
competing hemodynamic and geometric factors could not
be readily separated in vivo (5). Our in vitro model allowed
us to test these interactions; to show that postulated
changes, in fact, can induce regurgitation in this model, and
to demonstrate their overall similarity to clinical observa-
tions.
Normally, the mitral valve acts as an integrated system,
with dynamic changes in the relation between the annulus
and papillary muscle–chordae tendinae complex that permit
efficient closure throughout the systole (20). The model
reproduced at different time steps of the cardiac cycle the
instantaneous papillary muscle and annular relationships
that occur with akinetic or dyskinetic function of the left
ventricular posterior wall (13). Although the dynamic
changes of the left ventricle as a whole were not simulated,
the pressure and flow changes were. The fixation of the
papillary muscles to mounting rods even allowed us to
separate the chordal coapting forces and the tethering forces
in the chordal force measurements, which would be impos-
sible to accomplish in vivo.
Clinical implications. Even though any clinical implica-
tions of this model must be stated circumspectly, this in
vitro study can potentially help us to gain insight into
therapeutic interventions that modify mechanistic factors,
for example, the role of new surgical approaches that can
modify the geometric relationships, such as chordal recon-
struction (21), papillary muscle repositioning (20,22) and
resection of posterior wall myocardium between the papil-
lary muscles to move them closer together (23). Our study
indicates that remodeling of the mitral valve substructures
(e.g., chordal lengthening) may be a relevant surgical ap-
proach to “normalize” the chordal force distribution in
functional MR. However, one may be aware that chordal
lengthening itself, instead of “slackening the reins” of the
mitral leaflets, may adversely deteriorate left ventricular
function due to loss of support of the left ventricular wall
(valvular–ventricular interaction). Therefore, surgical cor-
rection could involve lengthening of the primary chordae,
possibly in combination with transposition or shortening of
the secondary (strut) chordae with the aim of improving
mitral valve function and interaction with the left ventricle.
Further studies on this issue are in progress.
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